Erydel's Unattributed VC Round

Erydel raised a round of funding on April 24, 2018.

EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken…

Articles about Erydel's Unattributed VC Round: